MetLife (NYSE:MET - Get Free Report) is projected to announce its Q1 2025 earnings results after the market closes on Wednesday, April 30th. Analysts expect MetLife to post earnings of $2.04 per share and revenue of $18.06 billion for the quarter.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, analysts expect MetLife to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.
MetLife Price Performance
NYSE MET opened at $73.06 on Wednesday. The stock's fifty day moving average price is $78.76 and its 200 day moving average price is $81.97. MetLife has a 1 year low of $65.21 and a 1 year high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $49.77 billion, a price-to-earnings ratio of 12.24, a PEG ratio of 0.65 and a beta of 0.89.
MetLife Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Stockholders of record on Tuesday, May 6th will be issued a $0.5675 dividend. This is an increase from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 annualized dividend and a dividend yield of 3.11%. MetLife's dividend payout ratio is 36.52%.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on MET. Morgan Stanley lowered their price target on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Piper Sandler increased their target price on shares of MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Barclays cut their price target on MetLife from $95.00 to $88.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Keefe, Bruyette & Woods lowered their price target on MetLife from $98.00 to $95.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Finally, BMO Capital Markets assumed coverage on MetLife in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $92.46.
Get Our Latest Analysis on MetLife
Institutional Inflows and Outflows
An institutional investor recently raised its position in MetLife stock. Brighton Jones LLC raised its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 9.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,240 shares of the financial services provider's stock after acquiring an additional 351 shares during the quarter. Brighton Jones LLC's holdings in MetLife were worth $347,000 as of its most recent filing with the Securities and Exchange Commission. 94.99% of the stock is owned by institutional investors and hedge funds.
About MetLife
(
Get Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
